All sponsors

Ipsen $IPN.PA

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS19
PHASE 3 / 2-310
RECRUITING7
READOUTS ≤12 MONTHS6
READOUT SLIPPED >6 MO50%

Delay Index: of 14 active trials registered more than a year ago, 7 have moved their primary completion (readout) date by more than 6 months since first registration (median +9.0 months). See all sponsors →

Open Ipsen on the live radar map → 📅 $IPN.PA readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ELATIVE
NCT04526665
P3Active, not recruitingPrimary Biliary Cirrhosis1612023-06-01 (-3 mo)
C-BEOND
NCT06047444
P3Active, not recruitingChronic Migraine7592026-05-28 (+12 mo)
E-BEOND
NCT06047457
P3Active, not recruitingEpisodic Migraine7512026-06-01 (+12 mo)
LAURITE 2
NCT07435428
P3Active, not recruitingModerate to Severe Glabellar Lines13002026-12-15
LAURITE 1
NCT07427797
P3Active, not recruitingModerate to Severe Glabellar Lines3092026-12-15
ELONSEN
NCT06730061
P3Active, not recruitingPrimary Biliary Cholangitis182026-12-17 (+9 mo)
CATALPA
NCT06937931
P2RecruitingCervical Dystonia1322027-03-26 (+14 mo)
LANTIC
NCT04821089
P1/2Active, not recruitingModerate to Severe Upper Facial Lines7272027-08-19 (+69 mo)
MERANTI
NCT06625060
P2Active, not recruitingEpisodic Migraine; Chronic Migraine6702027-10-31 (+5 mo)
IPN01194
NCT06305247
P1/2Active, not recruitingMelanoma; Head and Neck Squamous Cell Carcinoma362028-03-20
IPN01195
NCT06833008
P1/2Active, not recruitingAdvanced Solid Tumor422028-04-04 (-6 mo)
LAURITE 3
NCT07779252
P3RecruitingModerate to Severe Glabellar Lines1602028-04-10
IPN60300
NCT07213817
P1/2RecruitingLocally Advanced Solid Tumor; Metastatic Solid Tumor1142028-10-30
LANTIMA
NCT04752774
P1/2RecruitingSpasticity2402029-03-30 (+60 mo)
ELFIDENCE
NCT06016842
P3RecruitingPrimary Biliary Cholangitis (PBC)2762029-05-31 (-17 mo)
ELASCOPE
NCT07387549
P3RecruitingPrimary Sclerosing Cholangitis3502031-04-30
EVICTION 3
NCT07623187
P2/3Not yet recruitingAcute Myeloid Leukaemia (AML); Acute Myeloid Leukaemia5402031-05-31
ELMWOOD
NCT05627362
P2Active, not recruitingPrimary Sclerosing Cholangitis682031-09-23 (+91 mo)
IPN01203
NCT07213830
P1/2RecruitingAdvanced Solid Tumor; Metastatic Solid Tumor1022032-07-14